25I-NBOH

25I-NBOH

25I-NBOH
Systematic (IUPAC) name
2-((2-(4-iodo-2,5-dimethoxyphenyl)ethylamino)methyl)phenol
Identifiers
CAS Registry Number  N
PubChem CID:
ChemSpider  YesY
Chemical data
Formula C17H20INO3
Molecular mass 413.249 g/mol
 N   

25I-NBOH (NBOH-2CI, Cimbi-27) is a derivative of the phenethylamine derived hallucinogen 2C-I. It acts as a potent agonist for the 5HT2A receptor,[1][2] with a Ki of 0.061nM at the human 5HT2A receptor, similar to the better-known compound 25I-NBOMe, making it some twelve times the potency of 2C-I itself. In vitro tests showed this compound acted as an agonist but animal studies have not been reported. While the N-benzyl derivatives of 2C-I were significantly increased in binding activity to 5HT2A receptor fragments, compared to 2C-I, the N-benzyl derivatives of DOI were less active, compared to DOI.[3]

It was discovered in 2006 by a team at Purdue University.

See also

References

  1. ^
  2. ^
  3. ^